Skip to content

Armada A2040-040Recalls & reported problems

Abbott Vascular Inc. · Armada 14 PTA Catheter 4.0 mm x 40 mm x 150 cm / Over-The-Wire · Class 2

All models of Armada (213)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648156137), received between Nov 13, 2019 and Jun 10, 2026 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Material Rupture” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Rupture3
  • Leak/Splash1
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Insufficient Information1
  • No Consequences Or Impact To Patient1
  • No Patient Involvement1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 10, 2026Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 60% STENOSED LESION IN THE COMMON ILIAC ARTERY WITH MODERATE CALCIFICATION. THE 4X40MM ARMADA 14 BALLOON DILATATION CATHETER (BDC) WAS USED IN THE PROCEDURE; HOWEVER, THE BALLOON BURST DURING THE FIRST INFLATION AT 6 ATMOSPHERES (ATM). ANOTHER ARMADA BDC WAS USED TO CONTINUE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25462275 ↗
  • MalfunctionFeb 7, 2024Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT DURING PREPARATION OF THE 4X40MM ARMADA 14 BALLOON DILATATION CATHETER (BDC) WHEN PULLING NEGATIVE THE BDC CONTINUED TO PULL AIR. THE BDC WAS NOT USED IN THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18664517 ↗
  • MalfunctionApr 1, 2021Material Rupture; Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY CALCIFIED, MODERATELY TORTUOUS, 90% STENOSED LESION IN THE POPLITEAL ARTERY. A 4.0X40MM ARMADA 14 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER WAS PREPARED FOR USE, ADVANCED AND POSITIONED TO PRE-DILATE THE LESION. THE BALLOON WAS INFLATED TO NOMINAL PRESSURE, RUPTURED ON THE FIRST INFLATION. ANOTHER ARMADA PTA WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Insufficient Information

    MAUDE report 11606566 ↗
  • MalfunctionJan 11, 2021Material Rupture; Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LEFT UPPER ARM LOOP AXILLARY-AXILLARY AV GRAFT WITH POOR FUNCTION AND STENOSIS. THE 4.0X40MM ARMADA 14 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER WAS INFLATED AND RUPTURED AT AN UNKNOWN PRESSURE. NO RESISTANCE WAS NOTED DURING ADVANCEMENT, BUT THE PHYSICIAN THOUGHT THAT THE STENOSIS HAD A JAGGED EDGE, WHICH MIGHT HAVE CAUSED THE BALLOON TO RUPTURE. A NON-ABBOTT NON COMPLIANT BALLOON WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 11152333 ↗
  • MalfunctionNov 13, 2019Material Split, Cut or Torn; Material Split, Cut or Torn

    IT WAS REPORTED THAT DURING PREPARATION, THERE WAS A PINHOLE IN THE BALLOON OF A 4.0 X 40 MM ARMADA 14 BALLOON CATHETER AS THE DEVICE FAILED TO PRESSURIZE WHEN PULLING NEGATIVE AIR. THEREFORE, THE DEVICE WAS REPLACED WITH ANOTHER 4.0 X 40 MM ARMADA 14 BALLOON CATHETER TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Patient Involvement

    MAUDE report 9317382 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page